NASDAQ:CFFS CF Acquisition Corp. VII (CFFS) Stock Price, News & Analysis → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free CFFS Stock Alerts $10.84 0.00 (0.00%) (As of 05/8/2024 ET) Add Compare Share Share Today's Range$10.84▼$10.8450-Day Range$10.71▼$11.0052-Week Range$9.73▼$11.52VolumeN/AAverage Volume61,858 shsMarket Capitalization$111.44 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Get CF Acquisition Corp. VII alerts: Email Address Ad Behind the MarketsThe Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.Don't miss out on the "next Ozempic" >>> About CF Acquisition Corp. VII Stock (NASDAQ:CFFS)CF Acquisition Corp. VII does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the financial services, healthcare, real estate services, technology, and software industries. The company was incorporated in 2020 and is based in New York, New York.Read More CFFS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CFFS Stock News HeadlinesFebruary 1, 2024 | tmcnet.comState Street Completes Acquisition of CF Global TradingApril 16, 2023 | wsj.comCF Acquisition Corp. VII Cl AMay 8, 2024 | Behind the Markets (Ad)The Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.September 24, 2022 | thestreet.comCF Acquisition Corp. V Units Cons of 1 Sh -A- + 1/3 Wt NewsJune 10, 2022 | uk.finance.yahoo.comCF Acquisition Corp. VII (CFFS)May 14, 2022 | yahoo.comJohnny Depp trial: What we know about Amber Heard’s career, background and family lifeMay 14, 2022 | yahoo.comSpeed Week: FLO Racing Illinois Speedweek hits the area this weekendMay 14, 2022 | nz.finance.yahoo.comEmbattled Orpea Gets $1.8 Billion Financing as Debt LoomsMay 8, 2024 | Behind the Markets (Ad)The Weight Loss Pill That Could Disrupt a $32 Billion IndustryA revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.May 14, 2022 | yahoo.comJeff Bezos and Alexis Ohanian are pouring $50 million into NYC's childcare crisisMay 13, 2022 | finance.yahoo.comWhat Is The Ownership Structure Like For CF Acquisition Corp. VII (NASDAQ:CFFS)?See More Headlines Receive CFFS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CF Acquisition Corp. VII and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorUnclassified Industry N/A Sub-IndustryN/A Current SymbolNASDAQ:CFFS CUSIPN/A CIK1839519 WebN/A Phone212-938-5000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares10,280,000Free Float7,617,000Market Cap$111.44 million OptionableNot Optionable Beta-0.01 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Howard W. Lutnick (Age 62)Chairman & CEO Ms. Jane Novak (Age 59)Chief Financial Officer Key CompetitorsCartica AcquisitionNASDAQ:CITEPerception Capital Corp. IIINASDAQ:PFTATarget Global Acquisition INASDAQ:TGAACapitalworks Emerging Markets AcquisitionNASDAQ:CMCACompass Digital AcquisitionNASDAQ:CDAQView All CompetitorsInstitutional OwnershipBeryl Capital Management LLCBought 682,830 shares on 2/15/2024Ownership: 3.535%Berkley W R CorpBought 76,561 shares on 2/15/2024Ownership: 2.868%Cowen AND Company LLCBought 435,066 shares on 2/8/2024Ownership: 4.144%Mizuho Securities USA LLCSold 432,687 shares on 2/8/2024Ownership: 0.518%Robinson Capital Management LLCBought 30,000 shares on 2/8/2024Ownership: 0.155%View All Institutional Transactions CFFS Stock Analysis - Frequently Asked Questions How have CFFS shares performed in 2024? CF Acquisition Corp. VII's stock was trading at $10.85 on January 1st, 2024. Since then, CFFS stock has decreased by 0.1% and is now trading at $10.84. View the best growth stocks for 2024 here. Are investors shorting CF Acquisition Corp. VII? CF Acquisition Corp. VII saw a decline in short interest in April. As of April 15th, there was short interest totaling 100 shares, a decline of 80.0% from the March 31st total of 500 shares. Based on an average daily volume of 47,200 shares, the days-to-cover ratio is currently 0.0 days. View CF Acquisition Corp. VII's Short Interest. How do I buy shares of CF Acquisition Corp. VII? Shares of CFFS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CFFS) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe AI Stock that’s Disrupting Every IndustryStockEarnings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CF Acquisition Corp. VII Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
